文献速递牙周病

罗伊氏乳杆菌益生菌辅助改善残留牙周袋治疗

A dual-strain Lactobacilli reuteri probiotic improves the treatment of residual pockets: A randomized controlled clinical trial.
PubMed 文献 · J Clin Periodontol · 2019-11-14

一项随机双盲安慰剂对照试验纳入39例既往接受过非手术治疗牙周炎患者,在再行器械治疗后辅以罗伊氏乳杆菌滴剂和/或含片。滴剂未见效果,但含片组24周时总体探诊深度显著低于对照组,且牙周致病菌计数未受影响。

要点

  • 再器械治疗后辅以罗伊氏乳杆菌含片可降低24周总体探诊深度
  • 含片组由≥4 mm转为≤3 mm的牙周袋比例更高、需手术位点更少
  • 益生菌产品未改变牙周致病菌的微生物学计数

核心结论

  • 再器械治疗后辅助使用罗伊氏乳杆菌含片可改善探诊深度降低,但不影响牙周袋致病菌定植。

研究设计与样本

  • 随机、双盲、安慰剂对照研究,纳入39例既往接受过非手术治疗的牙周炎患者。

主要发现

  • 益生菌滴剂未见效果。
  • 24周时益生菌含片组总体PPD为2.64 ± 0.33 mm,显著低于对照组2.92 ± 0.42 mm。
  • 该差异在中度(4-6 mm)和深(≥7 mm)牙周袋中更明显。
  • 含片组由基线≥4 mm转为24周≤3 mm的牙周袋比例为67 ± 18%,对照组为54 ± 17%。
  • 含片组需手术位点比例为4 ± 4%,对照组为8 ± 6%。

关键数值与推荐

  • 24周总体PPD:益生菌含片组2.64 ± 0.33 mm vs 对照含片组2.92 ± 0.42 mm。
  • 牙周袋由≥4 mm转为≤3 mm比例:67 ± 18% vs 54 ± 17%。
  • 需手术位点比例:4 ± 4% vs 8 ± 6%。

临床怎么用

  • 对再器械治疗后的残留牙周袋,可考虑辅助使用罗伊氏乳杆菌含片以改善探诊深度。
  • 不应期待益生菌改变牙周致病菌计数。

局限性

  • 样本量39例,结果需更大样本验证。
  • 滴剂未见效果,含片与滴剂效果不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To examine the adjunctive effect of a Lactobacillus reuteri probiotic (ATCC PTA 5289 & DSM 17938) on the re-instrumentation of residual pockets. MATERIALS AND METHODS: This randomized, double-blind, placebo-controlled study included 39 previously non-surgically treated periodontitis patients. A re-instrumentation was carried out, and probiotic and/or placebo drops were applied according to the study protocoll. Patients afterwards received lozenges to use 2×/day for 12 weeks. Probing pocket depth (PPD), recession, bleeding on probing and plaque levels were analysed, next to the microbiological impact. RESULTS: No effects of the probiotic drops could be found. However, after 24 weeks, the overall PPD in the probiotic lozenges group (2.64 ± 0.33 mm) was significantly lower compared to the control lozenges (2.92 ± 0.42 mm). This difference was even more pronounced in moderate (4-6 mm) and deep (≥7 mm) pockets. In the probiotic lozenges group, there were also significantly more pockets converting from ≥4 mm at baseline to ≤3 mm at 24 weeks (67 ± 18% versus 54 ± 17%) and less sites in need for surgery (4 ± 4% versus 8 ± 6%). However, the probiotic products did not influence the microbiological counts of the periodontopathogens. CONCLUSION: The adjunctive consumption of L. reuteri lozenges after re-instrumentation improved the PPD reduction, without an impact on pocket colonization with periodontopathogens.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Laleman I, Pauwels M, Quirynen M, et al. A dual-strain Lactobacilli reuteri probiotic improves the treatment of residual pockets: A randomized controlled clinical trial. J Clin Periodontol. 2019. PMID: 31520543. doi:10.1111/jcpe.13198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。